BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Farmers Insurance
Fish and Richardson
Boehringer Ingelheim
Daiichi Sankyo
Chubb
Queensland Health
McKesson
Cantor Fitzgerald
Johnson and Johnson

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017794

« Back to Dashboard

NDA 017794 describes ATIVAN, which is a drug marketed by West-ward Pharms Int and Valeant Intl and is included in two NDAs. It is available from seven suppliers. Additional details are available on the ATIVAN profile page.

The generic ingredient in ATIVAN is lorazepam. There are eleven drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
Summary for 017794
Tradename:ATIVAN
Applicant:Valeant Intl
Ingredient:lorazepam
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 017794
Ingredient-typeBenzodiazepines
Medical Subject Heading (MeSH) Categories for 017794
Suppliers and Packaging for NDA: 017794
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATIVAN lorazepam TABLET;ORAL 017794 NDA Valeant Pharmaceuticals North America LLC 0187-0063 0187-0063-01 100 TABLET in 1 BOTTLE (0187-0063-01)
ATIVAN lorazepam TABLET;ORAL 017794 NDA Valeant Pharmaceuticals North America LLC 0187-0063 0187-0063-10 1000 TABLET in 1 BOTTLE (0187-0063-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Queensland Health
US Department of Justice
Boehringer Ingelheim
Julphar
Baxter
Citi
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot